← Leaderboards
Craig P Hersh
Brigham And Women'S Hospital
$16,648,360
Attributed
$17,813,705
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,813,705 · 10
By mechanism
R01$15,320,442 · 7
P01$1,693,315 · 1
K08$668,165 · 1
K24$131,783 · 1
Top collaborators
- Ingo Ruczinski2 shared
- Panagiotis V Benos1 shared
- Frank C. Sciurba1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Edwin K Silverman$89,199,838
- Edward P Ingenito$10,382,683
- George R Washko$16,445,968
- Michael H. Cho$16,257,579
- Adel El Boueiz$3,458,857
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesPathway InteractionsGene ExpressionSamplingGeneticPhenotypeChronic Obstructive Airway DiseaseResponsePulmonary EmphysemaComplementTranscriptome SequencingPeripheral BloodSingle Nucleotide PolymorphismGenetic EpidemiologyGenomicsGenome-WideGenome Wide Association StudySmokerGene Expression ProfilingGene Expression ProfileHeterogeneityData SetGenotypeCohort
Grant awards (33)
Defining a gene expression signature of airway disease, COPD exacerbations, and response to treatment$832,016
R01 · FY2025 · HL · contact PI
Defining the Role of Viral Infections and Autoantibodies in Chronic Obstructive Pulmonary Disease Progression$668,611
R01 · FY2025 · HL
Molecular Characterization Core$368,396
P01 · FY2025 · HL · contact PI
Patient oriented research and mentoring in COPD biomarker studies$131,783
K24 · FY2025 · HL · contact PI
Defining a gene expression signature of airway disease, COPD exacerbations, and response to treatment$815,376
R01 · FY2024 · HL · contact PI
Defining the Role of Viral Infections and Autoantibodies in Chronic Obstructive Pulmonary Disease Progression$675,739
R01 · FY2024 · HL
Molecular Characterization Core$299,217
P01 · FY2024 · HL · contact PI
Defining a gene expression signature of airway disease, COPD exacerbations, and response to treatment$833,806
R01 · FY2023 · HL · contact PI
Molecular Characterization Core$323,034
P01 · FY2023 · HL · contact PI
Molecular Characterization Core$322,844
P01 · FY2022 · HL · contact PI
COPD SUBTYPES AND EARLY PREDICTION USING INTEGRATIVE PROBABILISTIC GRAPHICAL MODELS$739,755
R01 · FY2021 · HL
Molecular Characterization Core$379,824
P01 · FY2021 · HL · contact PI
SYSTEMS GENOMICS OF THE ASTHMA-COPD OVERLAP SYNDROME$863,359
R01 · FY2019 · HL · contact PI
SYSTEMS GENOMICS OF THE ASTHMA-COPD OVERLAP SYNDROME$887,106
R01 · FY2018 · HL · contact PI
INTEGRATIVE GENOMICS OF CLINICAL SUBTYPES IN COPDGENE$860,223
R01 · FY2018 · HL · contact PI
SYSTEMS GENOMICS OF THE ASTHMA-COPD OVERLAP SYNDROME$887,102
R01 · FY2017 · HL · contact PI
INTEGRATIVE GENOMICS OF CLINICAL SUBTYPES IN COPDGENE$859,987
R01 · FY2017 · HL · contact PI
INTEGRATIVE GENOMICS OF CLINICAL SUBTYPES IN COPDGENE$891,352
R01 · FY2016 · HL · contact PI
SYSTEMS GENOMICS OF THE ASTHMA-COPD OVERLAP SYNDROME$887,101
R01 · FY2016 · HL · contact PI
INTEGRATIVE GENOMICS OF CLINICAL SUBTYPES IN COPDGENE$911,563
R01 · FY2015 · HL · contact PI
LONG-TERM OXYGEN TREATMENT TRIAL (LOTT) PHARMACOGENOMICS ANCILLARY STUDY$437,325
R01 · FY2014 · HL · contact PI
PHARMACOGENOMICS OF INHALED CORTICOSTEROIDS TO REDUCE COPD EXACERBATIONS$468,142
R01 · FY2013 · NR · contact PI
LONG-TERM OXYGEN TREATMENT TRIAL (LOTT) PHARMACOGENOMICS ANCILLARY STUDY$424,830
R01 · FY2013 · HL · contact PI
PHARMACOGENOMICS OF INHALED CORTICOSTEROIDS TO REDUCE COPD EXACERBATIONS$501,590
R01 · FY2012 · NR · contact PI
LONG-TERM OXYGEN TREATMENT TRIAL (LOTT) PHARMACOGENOMICS ANCILLARY STUDY$446,041
R01 · FY2012 · HL · contact PI
PHARMACOGENOMICS OF INHALED CORTICOSTEROIDS TO REDUCE COPD EXACERBATIONS$539,872
R01 · FY2011 · NR · contact PI
LONG-TERM OXYGEN TREATMENT TRIAL (LOTT) PHARMACOGENOMICS ANCILLARY STUDY$445,000
R01 · FY2010 · HL · contact PI
LONG-TERM OXYGEN TREATMENT TRIAL (LOTT) PHARMACOGENOMICS ANCILLARY STUDY$444,546
R01 · FY2009 · HL · contact PI
Fine Mapping of a COPD Locus on Chromosome 19q$133,633
K08 · FY2009 · HL · contact PI
Fine Mapping of a COPD Locus on Chromosome 19q$133,633
K08 · FY2008 · HL · contact PI
Fine Mapping of a COPD Locus on Chromosome 19q$133,633
K08 · FY2007 · HL · contact PI
Fine Mapping of a COPD Locus on Chromosome 19q$133,633
K08 · FY2006 · HL · contact PI
Fine Mapping of a COPD Locus on Chromosome 19q$133,633
K08 · FY2005 · HL